ECSP088588A - Uso de sales de tiotropio en el tratamiento del asma persistente moderada - Google Patents
Uso de sales de tiotropio en el tratamiento del asma persistente moderadaInfo
- Publication number
- ECSP088588A ECSP088588A EC2008008588A ECSP088588A ECSP088588A EC SP088588 A ECSP088588 A EC SP088588A EC 2008008588 A EC2008008588 A EC 2008008588A EC SP088588 A ECSP088588 A EC SP088588A EC SP088588 A ECSP088588 A EC SP088588A
- Authority
- EC
- Ecuador
- Prior art keywords
- treatment
- salts
- tiotrope
- moderate asthma
- persistent moderate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere al uso de sales de tiotropio para la preparación de un medicamento destinado al tratamiento de pacientes que padecen asma persistente moderada.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06100055 | 2006-01-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP088588A true ECSP088588A (es) | 2008-07-30 |
Family
ID=35695896
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2008008588A ECSP088588A (es) | 2006-01-04 | 2008-06-27 | Uso de sales de tiotropio en el tratamiento del asma persistente moderada |
Country Status (30)
Country | Link |
---|---|
US (2) | US20070155773A1 (es) |
EP (1) | EP1971332B1 (es) |
JP (1) | JP2009525950A (es) |
KR (1) | KR20080083060A (es) |
CN (1) | CN101355937A (es) |
AR (1) | AR059126A1 (es) |
AT (1) | ATE500825T1 (es) |
AU (1) | AU2006334367B2 (es) |
BR (1) | BRPI0620886A2 (es) |
CA (1) | CA2634984C (es) |
CY (1) | CY1111534T1 (es) |
DE (1) | DE602006020620D1 (es) |
DK (1) | DK1971332T3 (es) |
EA (1) | EA015353B1 (es) |
EC (1) | ECSP088588A (es) |
ES (1) | ES2362306T3 (es) |
HR (1) | HRP20110200T1 (es) |
IL (1) | IL192602A (es) |
ME (1) | ME01205B (es) |
MY (1) | MY146362A (es) |
NO (1) | NO20082439L (es) |
NZ (1) | NZ570162A (es) |
PL (1) | PL1971332T3 (es) |
PT (1) | PT1971332E (es) |
RS (1) | RS51703B (es) |
SI (1) | SI1971332T1 (es) |
TW (1) | TW200731976A (es) |
UA (1) | UA95271C2 (es) |
WO (1) | WO2007077162A1 (es) |
ZA (1) | ZA200804436B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ566399A (en) | 2005-08-06 | 2011-07-29 | Boehringer Ingelheim Int | Use of tiotropium salts in the treatment of severe persistant asthma |
WO2015065222A1 (ru) * | 2013-10-28 | 2015-05-07 | Шолекс Девелопмент Гмбх | Фармацевтический ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких, содержащий в качестве активного вещества микронизированный тиотропия бромид, и способ его получения |
GB201321717D0 (en) * | 2013-12-09 | 2014-01-22 | Pharmachemie Bv | Inhalable Medicaments |
CN110876720A (zh) * | 2018-09-06 | 2020-03-13 | 天津金耀集团有限公司 | 依地酸盐恰当改变噻托溴铵喷雾剂表面张力的应用 |
CN110876721A (zh) * | 2018-09-06 | 2020-03-13 | 天津金耀集团有限公司 | 一种含有表面活性剂的噻托溴铵喷雾剂 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2425539A (en) * | 1942-10-31 | 1947-08-12 | Aro Equipment Corp | Coupling |
DE3931041C2 (de) * | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
US5610163A (en) * | 1989-09-16 | 1997-03-11 | Boehringer Ingelheim Gmbh | Esters of thienyl carboxylic acids and amino alcohols and their quaternization products |
US6156503A (en) * | 1997-03-03 | 2000-12-05 | The Regents Of The University Of California | Diagnosing asthma patients predisposed to adverse β-agonist reactions |
GB9902689D0 (en) * | 1999-02-08 | 1999-03-31 | Novartis Ag | Organic compounds |
GB0009583D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Respiratory formulations |
US6908928B2 (en) * | 2000-10-12 | 2005-06-21 | Bi Pharma Kg. | Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions |
NZ525733A (en) * | 2000-10-12 | 2005-01-28 | Boehringer Ingelheim Pharma | Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament |
US6608055B2 (en) * | 2001-06-22 | 2003-08-19 | Boehringer Ingelheim Pharma Kg | Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition |
US6919325B2 (en) * | 2001-09-14 | 2005-07-19 | Boehringer Ingelheim Pharma Kg | Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts |
US7951557B2 (en) * | 2003-04-27 | 2011-05-31 | Protalix Ltd. | Human lysosomal proteins from plant cell culture |
SI2067779T1 (sl) * | 2003-11-03 | 2013-08-30 | Boehringer Ingelheim International Gmbh | Tiotropijeve soli, postopek za njihovo pripravo in formulacije zdravil, ki jih vsebujejo |
US7968717B2 (en) * | 2003-11-03 | 2011-06-28 | Boehringer Ingelhein International Gmbh | Crystalline anhydrate with anticholinergic efficacy |
CN100509809C (zh) * | 2003-11-03 | 2009-07-08 | 贝林格尔·英格海姆国际有限公司 | 具有抗胆碱能作用的新颖无水晶体 |
SE0303571D0 (sv) * | 2003-12-03 | 2003-12-22 | Microdrug Ag | Medical product for moisture-sensitive medicaments |
SE0303570L (sv) * | 2003-12-03 | 2005-06-04 | Microdrug Ag | Fukt-känslig medicinsk produkt |
EP1896607A4 (en) * | 2005-05-10 | 2009-12-16 | Synergenz Bioscience Ltd | METHOD AND COMPOSITIONS FOR THE ASSESSMENT OF LUNG FUNCTION AND RESPIRATORY DISEASE |
WO2006123943A1 (en) * | 2005-05-20 | 2006-11-23 | Synergenz Bioscience Limited | Methods of analysis of polymorphisms and uses thereof |
NZ566399A (en) * | 2005-08-06 | 2011-07-29 | Boehringer Ingelheim Int | Use of tiotropium salts in the treatment of severe persistant asthma |
US20070167480A1 (en) * | 2005-12-19 | 2007-07-19 | Sicor Inc. | Pure and stable tiotropium bromide |
-
2006
- 2006-12-22 KR KR1020087019159A patent/KR20080083060A/ko active Search and Examination
- 2006-12-22 MY MYPI20082435A patent/MY146362A/en unknown
- 2006-12-22 UA UAA200809746A patent/UA95271C2/ru unknown
- 2006-12-22 ES ES06830792T patent/ES2362306T3/es active Active
- 2006-12-22 PT PT06830792T patent/PT1971332E/pt unknown
- 2006-12-22 EP EP06830792A patent/EP1971332B1/en not_active Revoked
- 2006-12-22 NZ NZ570162A patent/NZ570162A/en unknown
- 2006-12-22 PL PL06830792T patent/PL1971332T3/pl unknown
- 2006-12-22 SI SI200630986T patent/SI1971332T1/sl unknown
- 2006-12-22 DE DE602006020620T patent/DE602006020620D1/de active Active
- 2006-12-22 CA CA2634984A patent/CA2634984C/en not_active Expired - Fee Related
- 2006-12-22 AT AT06830792T patent/ATE500825T1/de active
- 2006-12-22 AU AU2006334367A patent/AU2006334367B2/en active Active
- 2006-12-22 ME MEP-2011-62A patent/ME01205B/me unknown
- 2006-12-22 EA EA200801629A patent/EA015353B1/ru not_active IP Right Cessation
- 2006-12-22 RS RS20110147A patent/RS51703B/en unknown
- 2006-12-22 WO PCT/EP2006/070135 patent/WO2007077162A1/en active Application Filing
- 2006-12-22 BR BRPI0620886-0A patent/BRPI0620886A2/pt not_active Application Discontinuation
- 2006-12-22 CN CNA2006800504685A patent/CN101355937A/zh active Pending
- 2006-12-22 DK DK06830792.5T patent/DK1971332T3/da active
- 2006-12-22 JP JP2008548980A patent/JP2009525950A/ja active Pending
- 2006-12-28 US US11/617,320 patent/US20070155773A1/en not_active Abandoned
-
2007
- 2007-01-03 TW TW096100183A patent/TW200731976A/zh unknown
- 2007-01-03 AR ARP070100019A patent/AR059126A1/es active Pending
-
2008
- 2008-05-22 ZA ZA200804436A patent/ZA200804436B/xx unknown
- 2008-05-28 NO NO20082439A patent/NO20082439L/no not_active Application Discontinuation
- 2008-06-27 EC EC2008008588A patent/ECSP088588A/es unknown
- 2008-07-03 IL IL192602A patent/IL192602A/en active IP Right Grant
-
2011
- 2011-03-18 HR HR20110200T patent/HRP20110200T1/hr unknown
- 2011-06-07 CY CY20111100543T patent/CY1111534T1/el unknown
-
2015
- 2015-04-24 US US14/695,671 patent/US20150224090A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP12012318A (es) | Inhibidores de pirazolil quinazolina cinasa | |
CR20120283A (es) | Inhibidor de bromodominio de benzodiazepina | |
GT201400009A (es) | 4-imidazopiridazin-1-il-benzamidas y 4-imidazotriazin-1-il-benzamidas como inhibidores de btk | |
CL2012000248A1 (es) | Compuesto conjugado de insulina; procedimiento de preparacion; composicion farmaceutica que lo comprende; combinacion farmaceutica; kit farmaceutico; uso en el tratamiento de trastornos mediados por insulina. | |
CR11455A (es) | Compuestos nuevos de hidrocarbono ciclico para el tratamiento de enfermedades | |
AR092177A1 (es) | Metodos para tratar o prevenir asma administrando un antagonista de il-4r | |
SV2010003581A (es) | 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso | |
UY29899A1 (es) | Uso de flibanserina para el tratamiento de trastornos del deseo sexual premenopausicos | |
UY32455A (es) | Derivados de aminotetralina, composiciones farmacéuticas que la contienen, y sus usos en terapia | |
UY31922A (es) | Compuestos | |
SV2011003802A (es) | Derivados de triazol utiles para el tratamiento de enfermedades | |
BR112013029256A8 (pt) | combinação farmacêutica para uso no tratamento de pacientes com diabetes tipo 2 | |
ECSP088874A (es) | Uso de flibanserina para el tratamiento de trastornos posmenopausicos del deseo sexual | |
ECSP088745A (es) | Derivados sustituidos de cromanol y su uso | |
BR112014005025A2 (pt) | composição farmacêutica para uso no tratamento de uma doença neurodegenerativa | |
GT201400059A (es) | Derivados de estra-1,3,5(10),16-tetraen-3-carboxamida, proceidmientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparacion de medicamentos | |
BR112014012459A2 (pt) | 2h-indazóis como antagonistas do receptor de ep2 | |
UY33530A (es) | Composiciones farmacéuticas para el tratamiento de enfermedades respiratorias e inflamatorias | |
BRPI0911469A8 (pt) | Inibidores de gm-csf e il-17 para terapia | |
WO2009099553A3 (en) | Use of kinase inhibitor in treatment of atherosclerosis | |
ECSP088588A (es) | Uso de sales de tiotropio en el tratamiento del asma persistente moderada | |
EA201171414A1 (ru) | Ингибиторы белков семейства iap | |
DOP2010000400A (es) | 7-sulfanilmetil-,7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos | |
UY33723A (es) | ?COMPUESTOS Y SU USO PARA TRATAMIENTO DE ENFERMEDADES RELACIONADAS CON Aß?. | |
CR11755A (es) | Dronedarona para la prevencion de la cardioversion |